Microbix Biosystems Inc. – TSX:MBX.TO

Microbix Biosystems stock price today

CAD 0.83
+0.42
+102.44%
Financial Health
0
1
2
3
4
5
6
7
8
9

Microbix Biosystems stock price monthly change

+32.26%
month

Microbix Biosystems stock price quarterly change

+32.26%
quarter

Microbix Biosystems stock price yearly change

+7.89%
year

Microbix Biosystems key metrics

Market Cap
53.81M
Enterprise value
49.02M
P/E
-141.77
EV/Sales
2.93
EV/EBITDA
33.95
Price/Sales
3.31
Price/Book
2.36
PEG ratio
3.30
EPS
0.01
Revenue
19.64M
EBITDA
3.68M
Income
1.43M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-2.34%
Oper. margin
1.71%
Gross margin
54.35%
EBIT margin
1.71%
EBITDA margin
18.75%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Microbix Biosystems stock price history

Microbix Biosystems stock forecast

Microbix Biosystems financial statements

Microbix Biosystems Inc. (TSX:MBX.TO): Profit margin
Mar 2023 4.21M -169.75K -4.02%
Jun 2023 5.53M -769.10K -13.91%
Sep 2023 4.26M 1.99M 46.84%
Mar 2024 5.63M 377.73K 6.71%
Microbix Biosystems Inc. (TSX:MBX.TO): Analyst Estimates
2025 29.12M 2.75M 9.47%
2026 39.23M 6.89M 17.57%
  • Analysts Price target

  • Financials & Ratios estimates

Microbix Biosystems Inc. (TSX:MBX.TO): Debt to assets
Mar 2023 33194482 9.82M 29.61%
Jun 2023 34295095 11.65M 33.98%
Sep 2023 35653024 11.02M 30.93%
Mar 2024 37922214 10.16M 26.81%
Microbix Biosystems Inc. (TSX:MBX.TO): Cash Flow
Mar 2023 -1.05M -551.11K 903.25K
Jun 2023 2.13M -215.11K -228.69K
Sep 2023 -1.45M -117.85K -228.62K
Mar 2024 839.24K -637.90K -111.10K

Microbix Biosystems alternative data

Microbix Biosystems Inc. (TSX:MBX.TO): Employee count
Aug 2023 100
Sep 2023 100
Oct 2023 100
Nov 2023 100
Dec 2023 100
Jan 2024 100
Feb 2024 100
Mar 2024 100
Apr 2024 100
May 2024 100
Jun 2024 100
Jul 2024 100

Microbix Biosystems other data

  • What's the price of Microbix Biosystems stock today?

    One share of Microbix Biosystems stock can currently be purchased for approximately $0.83.

  • When is Microbix Biosystems's next earnings date?

    Microbix Biosystems Inc. is estimated to report earnings on Tuesday, 5 Aug 2025.

  • Does Microbix Biosystems pay dividends?

    No, Microbix Biosystems does not pay dividends.

  • How much money does Microbix Biosystems make?

    Microbix Biosystems has a market capitalization of 53.81M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 53.77% to 25.39M US dollars.

  • What is Microbix Biosystems's stock symbol?

    Microbix Biosystems Inc. is traded on the TSX under the ticker symbol "MBX.TO".

  • What is Microbix Biosystems's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Microbix Biosystems?

    Shares of Microbix Biosystems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Microbix Biosystems have?

    As Jul 2024, Microbix Biosystems employs 100 workers.

  • When Microbix Biosystems went public?

    Microbix Biosystems Inc. is publicly traded company for more then 29 years since IPO on 13 Aug 1996.

  • What is Microbix Biosystems's official website?

    The official website for Microbix Biosystems is microbix.com.

  • Where are Microbix Biosystems's headquarters?

    Microbix Biosystems is headquartered at 265 Watline Avenue, Mississauga, ON.

  • How can i contact Microbix Biosystems?

    Microbix Biosystems's mailing address is 265 Watline Avenue, Mississauga, ON and company can be reached via phone at +90 53618910.

Microbix Biosystems company profile:

Microbix Biosystems Inc.

microbix.com
Exchange:

TSX

Full time employees:

100

Industry:

Biotechnology

Sector:

Healthcare

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

265 Watline Avenue
Mississauga, ON L4Z 1P3

:
ISIN: CA59501P1045
CUSIP: 59501P104